[1]
2023. The Use of the [99mTc]Tc-DARPinG3 in Assessing Tumor Process in a Patient with Metastatic HER2-Positive Breast Cancer (Clinical Case Report). Voprosy onkologii. 69, 5 (Nov. 2023), 917–922. DOI:https://doi.org/10.37469/0507-3758-2023-69-5-917-922.